author-photo

Gioia Colafigli

Sapienza University of Rome

71

Papers

328

Citations

Citation Trend

Filter By

Papers (51) Sort By

Journal Conference Others

A NEW TYPE-2-LIKE CALR MUTATION IN ESSENTIAL THROMBOCYTHEMIA

2021
Show All
- Source
- Cite
- Save
Citations (0)
Long-term follow-up of late chronic phase chronic myeloid leukemia patients treated with imatinib after interferon failure: a single center experience.

2021 Leukemia & Lymphoma
Show All
- Source
- Cite
- Save
Citations (0)
Asciminib: an investigational agent for the treatment of chronic myeloid leukemia.

2021 Expert Opinion on Investigational Drugs
Show All
- Source
- Cite
- Save
Citations (1)
Real-life comparison of nilotinib versus dasatinib as second-line therapy in chronic phase chronic myeloid leukemia patients.

2021 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (1)
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols.

2021 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (0)
Measuring prognosis in chronic myeloid leukemia: what's new?

2021 Expert Review of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Long term follow-up of frontline Dasatinib in older patients with chronic myeloid leukemia in chronic phase treated outside clinical trials: a real-life cohort observational study.

2021 Acta Oncologica
Show All
- Source
- Cite
- Save
Citations (0)
Therapeutic strategies in low and high-risk MDS: What does the future have to offer?

2020 Blood Reviews
Show All
- Source
- Cite
- Save
Citations (7)
Tyrosine kinase inhibitor discontinuation in the management of chronic myeloid leukemia: a critical review of the current practice.

2020 Expert Review of Hematology
Show All
- Source
- Cite
- Save
Citations (3)
The advantages and risks of ruxolitinib for the treatment of polycythemia vera.

2020 Expert Review of Hematology
Show All
- Source
- Cite
- Save
Citations (1)